Literature DB >> 9056011

Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolates.

D E Taylor1, A S Chau.   

Abstract

The gyrA gene of Campylobacter fetus subsp. fetus, which encodes the A subunit of DNA gyrase, was cloned, and its nucleotide sequence was determined. An open reading frame of 2,586 nucleotides which encodes a polypeptide of 862 amino acids with an Mr of 96,782 was identified. C. fetus subsp. fetus GyrA is most closely related to Campylobacter jejuni GyrA, with 73% homology at the nucleotide level and 78% identity between polypeptides. The next most closely related GyrA was that from Helicobacter pylori, with both DNA homology and amino acid identity of 63%. The gyrA and gyrB (DNA gyrase B subunit) genes were located on the genomic map of C. fetus subsp. fetus ATCC 27374 and shown to be separate. A clinical isolate of C. fetus subsp. fetus and a laboratory-derived mutant of ATCC 27374, both resistant to ciprofloxacin, had identical mutations within the quinolone resistance determining region. In both mutants a G-->T transversion, corresponding to a substitution of Asp-91 to Tyr in GyrA, was linked to ciprofloxacin resistance, giving MICs of 8 to 16 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9056011      PMCID: PMC163769     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Characterization of high-level quinolone resistance in Campylobacter jejuni.

Authors:  T D Gootz; B A Martin
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction.

Authors:  M Oram; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

3.  New topoisomerase essential for chromosome segregation in E. coli.

Authors:  J Kato; Y Nishimura; R Imamura; H Niki; S Hiraga; H Suzuki
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

4.  Double-stranded DNA sequencing with T7 polymerase.

Authors:  Y Wang
Journal:  Biotechniques       Date:  1988-10       Impact factor: 1.993

5.  Extraintestinal Campylobacter infections.

Authors:  M J Blaser
Journal:  West J Med       Date:  1986-03

6.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

7.  Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.

Authors:  M E Cullen; A W Wyke; R Kuroda; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

8.  Expanded genomic map of Campylobacter jejuni UA580 and localization of 23S ribosomal rRNA genes by I-CeuI restriction endonuclease digestion.

Authors:  E Newnham; N Chang; D E Taylor
Journal:  FEMS Microbiol Lett       Date:  1996-09-01       Impact factor: 2.742

9.  Small-scale DNA preparation for rapid genetic identification of Campylobacter species without radioisotope.

Authors:  T Ezaki; N Takeuchi; S L Liu; A Kai; H Yamamoto; E Yabuuchi
Journal:  Microbiol Immunol       Date:  1988       Impact factor: 1.955

10.  Routes of quinolone permeation in Escherichia coli.

Authors:  J S Chapman; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

View more
  11 in total

1.  Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.

Authors:  J Okuda; E Hayakawa; M Nishibuchi; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000.

Authors:  Carole Tremblay; Christiane Gaudreau; Manon Lorange
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

3.  Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies.

Authors:  Jyh-Ming Liou; Chi-Yang Chang; Wang-Huei Sheng; Yu-Chi Wang; Mei-Jyh Chen; Yi-Chia Lee; Hsu-Wei Hung; Hung Chian; San-Chun Chang; Ming-Shiang Wu; Jaw-Town Lin
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

4.  Campylobacter curvus-associated hepatic abscesses: a case report.

Authors:  Nicole M Wetsch; Karim Somani; Gregory J Tyrrell; Carol Gebhart; R J Bailey; Diane E Taylor
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

5.  Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.

Authors:  C Tremblay; C Gaudreau
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

Review 6.  Mechanisms of fluoroquinolone resistance: an update 1994-1998.

Authors:  L J Piddock
Journal:  Drugs       Date:  1999       Impact factor: 9.546

7.  Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field.

Authors:  E Giraud; A Brisabois; J L Martel; E Chaslus-Dancla
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

8.  Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.

Authors:  Amera Gibreel; Veronica N Kos; Monika Keelan; Cathy A Trieber; Simon Levesque; Sophie Michaud; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing.

Authors:  Antti Hakanen; Jari Jalava; Pirkko Kotilainen; Hannele Jousimies-Somer; Anja Siitonen; Pentti Huovinen
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Differentiation of Campylobacter jejuni serotype O19 strains from non-O19 strains by PCR.

Authors:  N Misawa; B M Allos; M J Blaser
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.